528 Intratumoural treatment with LTX-, an oncolytic peptide immunotherapy, in patients with advanced metastatic disease induces CD8 effector cells and regression in some injected tumours. (September 2015) - Spicer, J.; Awada, A.; Brunsvig, P.; Saunders, A.; Olsen, W.M.; Nicolaisen, B.; Rekdal, O.; Laruelle, M.; Marjuadi, F.; Vakili, J.; Aftimos, P.; Barthelemy, P.; et al.